For peptides, therefore, this tells you: What percentage of the sample is the target peptide (BPC-157) What percentage consists of impurities, degradation products, or other compounds What to look for on the COA: Testing method listed as HPLC or RP-HPLC (Reverse-Phase HPLC) Purity percentage: Should be 99% for research-grade peptides Chromatogram: The visual graph showing the HPLC results (peak should be clean and well-defined) 3
Monitoring GGT levels helps detect and track diseases like atherosclerosis, autoimmune disorders, infections, cancer, and organ damage
Health-related topics and scientific findings are subject to change over time, and we encourage readers to consult reliable sources and medical professionals for the most up-to-date information
Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157
Taking an Active Role with At-Home Monitoring The waiting game for answers can be incredibly stressful